MONTREAL – The landscape of precision medicine in Canada has reached a major technological milestone today. In a strategic collaboration uniting visionary ambition with the operational excellence of current practices, the… Read More
Dr. Sofia Arshavsky-Graham did not always imagine a career in science. That changed when she was introduced to biotechnology and saw how biology and engineering could work together to address real medical needs…. Read More
Application supported by Phase 3 data reinforcing teclistamab regimens as a potential standard of care after at least one prior therapy1 Teclistamab monotherapy delivered superior progression-free survival and overall survival… Read More
Idorsia and Pharmalink enter into an exclusive distribution and commercialization agreement for QUVIVIQ™ (daridorexant) in the United Arab Emirates (UAE), Kuwait, Qatar, Oman, and Bahrain Allschwil, CH – Idorsia Ltd has… Read More
BIOTECanada welcomes the launch of the National Research Council of Canada’s Biomedical Countermeasures Initiative, introduced as part of the federal government’s Defence Industrial Strategy. It is an important step in… Read More
